Source: http://www.readbag.com/accessdata-fda-cdrh-docs-pdf4-k041876
Timestamp: 2019-05-24 03:23:45
Document Index: 91366937

Matched Legal Cases: ['arts 800', 'art 807', 'art 801', 'art 820', 'art 801', 'art 807', 'art 21']

Read K041876.pdf
Read K041876.pdf text version
A\UG 202004
K04\31&amp;
Elizabeth J. Mason Sr. Regulatory Affairs Specialist Nobel Biocare USA Inc. 22715 Savi Ranch Parkway Yorba Linda, CA 92887 (714) 282-4800, ext. 7830 (714) 998-9348 July 9, 2004 Endlosseous Implant (21 CFR 872.3640) Nobeloirectmt 00 Implant
51 0(k) Summary of Safety and Effectiveness
Submitted by: Address:
Telephone: Facsimile: Date of Submission: Classification Name: Trade or Proprietary or Model Name: Legally Marketed Device(s):
Br~nemark System Implants (K022562) Replace One-Piece Implants (K023952)
DeviceDscitin Nobel Biocare's NobeloirectTM 00 Implant is a threaded one-piece root form endosseous implant with an integrated ball attachment designed for one-stage surgical procedures and overdenture restorations. The NobeloirectTM 00 Implant is intended to provide immediate retention for removable tissue supported lower overdentures in fully edentulous jaws. Nobel Biocare's NobeloirectTM 0D Implant can be placed in an edlentulous arch or placed simultaneously with tooth extraction. When using the Nobel Biocare's Nobeloirectm OD Implant in immediate function applications, it is essential to obtain primary implant stability. Nobel Biocare's Gold Cap for Ball TM Attachment is to be utilized with the NobelDirect 00 Implant. Nobel Biocare's NobeloirectTM 00 Implant is machined from titanium and is available with a straight or tapered contour. The NobelDirect&quot;~ 00 Implant has a surface treatment that consists of a titanium oxide layer (TiUnite) that extends over the implant threads and onto the implant collar
Indications for Use: The Nobelloirectm 00 Implant is a root form endlosseous implant intended to provide immediate retention for removable tissue supported lower dentures in fully edentulous patients.
Nobel Biocare Traditional 510(k) Notification Nobel~irect&quot;' 00 Implant July 2004
Public teatth Service
Food and Drug Administration 9200 Corporate Boulevard
Ms. Elizabeth J. Mason Senior Regulatory Affairs Specialist Nobel Biocare USA, Incorporated 22715 Savi Ranch Parkway Yorba Linda, California 92887
20a04o 0
Re: K041876 Trade/Device Name: NobelDirectTM OD Implant Regulation Number: 872.3640 Regulation Name: Endosseous Implant Regulatory Class: II Product Code: DZE Dated: July 9, 2004 Received: July 21, 2004
Dear Ms. Mason: of intent to market the device We have reviewed your Section 510(k) premarket notification equivalent (for the referenced above and have determined the device is substantially predicate devices marketed in indications for use stated in the enclosure) to legally marketed date of the Medical Device interstate commerce prior to May 28, 1976, the enactment in accordance with the provisions of Amendments, or to devices that have been reclassified do not require approval of a premarket the Federal Food, Drug, and Cosmetic Act (Act) that the device, subject to the general approval application (PMA). You may, therefore, market provisions of the Act include controls provisions of the Act. The general controls good manufacturing practice, requirements for annual registration, listing of devices, labeling, and prohibitions against misbranding and adulteration. 11 (Special Controls) or class Ill If your device is classified (see above) into either class Existing major regulations affecting (PMA), it may be subject to such additional controls. Title 21. Parts 800 to 898. In your device can be fOund in the Code of Federal Regulations, your device in the Federal addition, FDA may publish further announcements concerning Register.
Page 2 - Ms. Mason determination does not Please be advised that FDA's issuance of a substantial equivalence with other rcu r-,'icflt mcan that FDA has nadc a determination that your device complies by other Federal agencies. of the Act or any Federal statutes and regulations administered but not limited to: registration You must comply with all the Act's requirements, including, good manufacturing practice and listing (21 CFR Part 807); labeling (21 CFR Part 801); (21 CFR Part 820); and if requirements as set forth in the quality systems (QS) regulation (Sections 53 1-542 of the Act); applicable, the electronic product radiation control provisions 21 CFR 1000-1050. as described in your Section 5 10(k) This letter will allow you to begin marketing your device of your device to a premarket notification. The FDA finding of substantial equivalence for your device and thus, permits legally marketed predicate device results in a classification your device to proceed to the market. regulation (21 CFR Part 801), If you desire specific advice for your device on our labeling Also, please note the regulation please contact the Office of Compliance at (301) 594-4613. (21CFR Part 807.97). You entitled, &quot;Misbranding by reference to premarket notification&quot; under the Act from the may obtain other general information on your responsibilities Assistance at its toll-free Division of Small Manufacturers, International and Consumer address number (800) 638-2041 or (301) 443-6597 or at its Internet
1hiu
Lin, Ph.D
Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Device Name: NobelDirect&quot;' OD Implant Indications For Use: The NobelDirect TM OD Implant is a root form endosseous implant intended to provide M 1 immediate retention for a removable tissue-supported overdenture. The NobelDirect OD Implant is used in the intra-foraminal area of the anterior mandible for the fully edentulous lower arch.
(21 CFR 807 Subpart C)
(Part 21 CFR 801 Subpart D)
IF (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE NEEDED)
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices 510(k) Number: ,
)@ 7